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Abstract  
Background: 
 The assay of pharmaceutical preparations containing more than 
one active ingredient often represents difficulties that face analysts. 
Methods that allow the easy determination of each ingredient in 
presence of the others are needed. Such methods should be selective, 
sensitive, easy to perform and not costly. 
Objective: 
 The aim of this research is to develop a simple, easy to conduct 
and economical method for the assay of drug combinations in 
pharmaceutical formulations. Dexamethasone sodium phosphate and 
chloramphenicol, dorzolamide hydrochloride and timolol maleate and 
antazoline hydrochloride and tetrahydrozoline hydrochloride were 
selected to be analyzed. 
Method: 
 The present work presents the development, optimization, 
validation and application of three High Performance Liquid 
Chromatographic methods for the assay of three combinations of 
drugs in ophthalmic formulations. 
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Results: 
The linearity range   (r2 value >0.98) was 16-64 µg/ml and 80-
320 µg/ml for dexamethasone sodium phosphate and chloramphenicol 
respectively. The mobile phase was acetonitrile and 5%v/v: glacial 
acetic acid, 36:64v/v 
The linearity range (r2 value > 0.98) was 120-480 µg/ml and 
360-1440 µg/ml for timolol maleate and dorzolamide hydrochloride 
respectively. The mobile phase was acetonitrile, tetrahydrofuran and 
1% phosphoric acid aqueous solution, 15:3:82 v/v. 
Determination of both drugs was possible over the range 12-
48µg/ml and 20-80µg/ml for tetrahydrozoline hydrochloride and 
antazoline hydrochloride respectively (r2 value >0.99). Repeatability 
and reproducibility were checked and relative standard deviations 
were found to be lower than 2%. The mobile phase was acetonitrile, 
tetrahydrofuran and 1%v/v phosphoric acid aqueous solution in the 
ratio 18: 5: 77 (v/v). 
Conclusion: 
The three developed methods are considered simple, linear, 
accurate, and sensitive and reproducible. These methods can be 
successfully used for the routine quality control of all three 
combinations within a short analysis time (less than 10 minutes). Each 
method can also be utilized for the assay of each drug alone using 
either compound as internal standard for the other.  
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review 
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1.1. The eye 
 The human eye is an organ which reacts to light for several 
purposes. As a conscious sense organ, the eye 
allows vision. Rod and cone cells in the retina allow conscious light 
perception and vision including color differentiation and the 
perception of depth. The human eye can distinguish about 10 million 
colors (1). 
1.2. Eye infections 
 Most cases of acute bacterial infections are self limiting; where 
the treatment is appropriate, antibacterial eye drops or ointments are 
used. A corticosteroid when combined with an anti-infective drug is 
usually used after surgery to reduce inflammation and prevent 
infection. One of the marketed combinations is Spersadex comp.®, 
which contains dexamethasone sodium phosphate and 
chloramphenicol (2). 
1.2.1. Dexamethasone sodium phosphate 
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C22H28FNa2O8Pi i 516.4 
 
Dexamethasone is 9-Fluoro-11b,17-dihydroxy-16a-methyl-
3,20-dioxopregna-1,4-dien-21-yl disodium phosphate, one of the most 
potent corticosteroids; it is 5 -14 times more potent than prednisolone 
and 25 - 75 times more potent than cortisone and hydrocortisone (3, 
4). Dexamethasone is administered locally to the eye for treating 
anterior segment inflammation, even that which results from surgery. 
It’s applied frequently for the first 24-48 hours; when the 
inflammation is controlled, it is applied less frequently. Three main 
dangers are coupled with the use of corticosteroids: ‘red eye’ where 
the diagnosis is unconfirmed they may aggravate the condition, 
‘steroid glaucoma’ and ‘steroid cataract’. Other side-effects include 
thinning of the cornea and sclera (2). 
1.2.2. Chloramphenicol 
 
 
C11H12Cl2N2O5    i i 323.1 
 
Chloramphenicol is 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-
(hydroxymethyl)-2-(4-nitrophenyl) ethyl]acetamide, produced by the 
growth of certain strains of Streptomyces venezuelae in a suitable 
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medium. It is normally prepared synthetically (3, 4). Chloramphenicol 
is a broad spectrum antibiotic and is the drug of choice for superficial 
eye infections. Its eye drops are well tolerated and the 
recommendation that they should be avoided because of an increased 
risk of aplastic anaemia is not well founded. Frequency of application 
depends on the severity of the infection and the potential for 
irreversible ocular damage; antibacterial eye drops are usually applied 
as one drop at least every two hours, the frequency of application is 
reduced with the infection being under control, the drug is continued 
48 hours after healing (2). 
1.3. Glaucoma 
British National Formulary defines glaucoma as “a disease 
which describes a group of disorders characterized by a loss of visual 
field associated with cupping of the optic disk and optic nerve 
damage”. While glaucoma is generally associated with raised intra-
ocular pressure, it can occur when the intra-ocular pressure is within 
the normal range. Glaucoma is managed using drugs that reduce intra-
ocular pressure for example a beta-blocker or a prostaglandin 
analogue. It might be necessary to combine these drugs with miotics, 
sympathomimetics, or carbonic anhydrase inhibitors, to control intra-
ocular pressure (2). One of the marketed eye drops in Sudan for the 
treatment of glaucoma is XolamolTM, which is a combination of 
timolol maleate and dorzolamide hydrochloride. 
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1.3.1. Timolol maleate 
 
 
 
 
C13H24N4O3S,C4H4O4 i i 432.5i  
Timolol maleate is (2S)-1-[(1,1-dimethylethyl)amino]-3-[[4-
(morpholin-4-yl)-1,2,5-thiadiazol-3-yl] oxy]propan-2-ol (Z)-
butenedioate, a beta-adrenoceptor antagonist which is formulated as 
eye drops for the treatment of glaucoma (3). Topical application of a 
beta-blocker to the eye reduces intra-ocular pressure effectively; this 
is due to reduction of the rate of production of aqueous humour. The 
administration of a beta-blocker by mouth also reduces intra-ocular 
pressure but this route is not used since side-effects may be 
troublesome. Topical application to the eyes may also be followed by 
systemic absorption; therefore, eye drops containing a beta-blocker 
are contra-indicated in patients with heart block, bradycardia, or 
uncontrolled heart failure. It is also important to state that they should 
be avoided in asthmatic patients. Other side-effects of eye drops 
include ocular stinging, burning, pain, itching, erythema, dry eye and 
allergic reactions (2). 
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 1.3.2. Dorzolamide hydrochloride
C10H16N2O4S3
Dorzolamide hydrochloride is
methyl-5,6-dihydro
dioxide hydrochloride,
treatment of glaucoma and ocular hypertension
reduces the intra
production. It is used topically in patients resistant to beta
those in whom beta
combined with 
rarely rise following systemic absorption 
discontinuation if severe. Other side
dry mouth; headache, asthenia; ocular irritation, blurred vision, 
lacrimation, conjunctivit
1.4. Allergic conjunctivitis
Allergic conjunctivitis
eyelids (conjunctiva)
cause is an allergy to pollen in the hay fever sea
less common such as allergies to house dust mite, cosmetics, an
 
ϲ 
 
  .HCl 
.HCl  360.9 
 (4S,6S)-
-4H-thieno[2,3-b]thiopyran-2-sulphonamide 
 a Carbonic anhydrase inhibitor; 
 
-ocular pressure by reducing the aqueous humour 
-blockers are contra-indicated. It is used alone or 
a topical beta-blocker. Sulphonamide
and may require 
-effects are nausea, bitter taste, 
is and rarely hypersensitivity reactions
 
 is inflammation of the tissue lining the 
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problems with contact lenses. Antihistamines and decongestants are 
commonly used for the treatment of allergic conjunctivitis (2). 
Apillerg and OptizolinTM, eye drops marketed in Sudan are 
combination of antazoline hydrochloride and tetrahydrozoline 
hydrochloride. 
1.4.1. Antazoline hydrochloride 
          
C17H19N3.HCl    301.8 
Antazoline hydrochloride is N-benzyl-N-[(4,5-dihydro-1H-
imidazol-2-yl)methyl] aniline hydrochloride (3). Antazoline exerts 
antiallergic activity by competitive reversible blockade of the H1 
receptor site on tissues; it reduces the effect of histamine released in 
the tissue by counteracting the increase in vascular permeability and 
expansion of the capillaries. The dose for adults and children over five 
years is 2-3 times daily, it should be used with caution in patients 
susceptible to angle-closure; absorption of antazoline may result in 
systemic side-effects and the possibility of interaction with other 
drugs (2).  
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1.4.2. Tetrahydrozoline hydrochloride 
      
C13H16N2.HCl    236.7 
Tetrahydrozoline hydrochloride is 2-[(1RS)-1,2,3,4-
Tetrahydronaphthalen-1-yl]-4,5-dihydro-1H-imidazole hydrochloride, 
an adrenoceptor agonist; decongestant (3). Tetrahydrozoline is a 
sympathomimetic agent with alpha adrenergic activity and is useful as 
a conjunctival decongestant. It acts as a local vasoconstrictor reducing 
the swelling and congestion in the mucus membranes of the 
conjunctiva. The dose is 1-2 drops into the affected eye(s) up to 4 
times daily; in acute cases one drop every three hours. Not for use by 
individuals with narrow angle glaucoma. 
1.5. Literature review 
 Several methods have been reported for the analysis of these 
drugs whether single or in combinations using different techniques. 
1.5.1. Dexamethasone sodium phosphate and chloramphenicol 
Dexamethasone sodium phosphate is assayed 
spectrophotometrically by measuring the absorbance at 241.5 nm (3). 
Chloramphenicol is also assayed spectrophotometrically by 
measuring the absorbance at 278nm (3). 
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 An HPLC method for the determination of dexamethasone, 
dexamethasone sodium phosphate and chloramphenicol in presence of 
each other in pharmaceutical preparations has been developed using a 
Shim-Pack CLC-ODS column (6.0 · 150 mm2). The mobile phase 
was composed of a mixture of the buffer solution, acetonitrile and 
methanol mixed in the ratio of 1.73:1.16:1, at a flow rate of 
0.5ml/min, at 50? C, and detection at 254nm. These analytes were 
separated under isocratic conditions. Various chromatographic 
parameters including linearity, precision and accuracy have been 
evaluated (5). 
Another HPLC method for the quantification of this 
combination (6) utilized a ZORBAX-ODS (4.6mm*150.0mm) as a 
column; the mobile phase was methanol 0.05mol/L potassium 
dihydrogen phosphate (55:45), at wavelength 242nm. The linearity 
range for dexamethasone sodium phosphate was 0.16-0.8g and 1.6-8g 
for chloramphenicol, the correlation coefficient was 0.9999 for 
calibration curves of both (6). 
One method for the determination of a combination of these 
drugs in an ointment was reported using HPLC. The mobile phase was 
(70:30) methanol: water, the determination wavelength was at 240nm, 
at a flow rate of 0.7ml/min (7). 
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1.5.2. Dorzolamide hydrochloride and timolol maleate 
Dorzolamide hydrochloride is assayed by carrying out a 
potentiometric titration, using 0.1M sodium hydroxide (3). 
Timolol maleate is assayed by titration against 0.1M perchloric 
acid, the end point is determined potentiometrically (3). 
Only one HPLC method has been reported for the 
determination of both dorzolamide and timolol in combined form. In 
this method the drugs were monitored with a diode-array detector at 
two fixed wavelengths (250nm and 300nm for dorzolamide 
hydrochloride and timolol maleate respectively). The linearity of the 
method ranged between 4.0–45.0 µ g · ml–1 for dorzolamide 
hydrochloride and 2.0–20.6 µ g · ml–1 for timolol maleate in binary 
mixture, indicating sensitivity of the method (8). 
Two-component mixtures of dorzolamide hydrochloride and 
timolol maleate were assayed by first derivative and ratio derivative 
spectrophotometric methods. The first method, derivative 
spectrophotometry, by the zero-crossing measurements, was used due 
to the drugs closely overlapping absorption spectra. Linear calibration 
graphs of first derivative values were monitored at 250.3 nm for 
dorzolamide hydrochloride and 315.8 nm for timolol maleate. The 
second method is based on ratio first derivative spectrophotometry, 
the amplitudes in the first derivative of the ratio spectra at 242.9 and 
at 223.5 nm were selected to determine dorzolamide and timolol 
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maleate in the binary mixture. Calibration graphs were established for 
8.0-30.0 µ g ml ' for dorzolamide hydrochloride and 3.0-24.6 µ g ml-
1 for timolol maleate in binary mixture. Good linearity, precision and 
selectivity were found, and the proposed methods were applied 
successfully to the pharmaceutical dosage from containing the above-
mentioned drug combination without any interference by the 
excipients. Vierordt's method was also developed as a comparison 
method (9, 10). 
1.5.3. Antazoline hydrochloride and tetrahydrozoline 
hydrochloride 
Reported methods for the assay of tetrahydrozoline, either alone 
or in combination, include colorimetry (USPXXIV) (4), HPLC 
methods with octadecyl-silyl silica (ODS) column (11-14), ion pairing 
technique (15-17), ODS column with buffering mobile phase (18,19) 
and gas chromatography (20). 
For antazoline, the reported methods for assay of the drug or its 
combination include titration for antazoline, in the raw material form, 
against alcoholic potassium hydroxide (3), liquid chromatographic 
method (12, 17) and reversed-phase ion-pair HPLC method (16).  
An HPLC method using bared silica column eluted with 
aqueous solvent mobile phase for determination of tetrahydrozoline 
hydrochloride in ophthalmic preparations. A mixture of methanol and 
water (70:30, v/v) containing 0.03% triethylamine and 0.02% acetic 
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acid was used as mobile phase, and chlorpheniramine maleate as an 
internal standard. The flow rate was 1 ml/min and the detection was at 
254 nm. The quantification limit was 1.0 µg/ml. Average recoveries 
range from 98.9 to 99.9%. The linearity of the calibration curve of 
tetrahydrozoline hydrochloride was well correlated (r = 0.9996) 
within the range from 12.5 to 500 µg/mL as well as from 1.0 to 
20µg/mL (r= 0.9997). This study further reports a simple and quick 
method for routine quantitative analysis of tetrahydrozoline 
hydrochloride in an ophthalmic solution (13). 
1.6. Drug stability 
 Stability of pharmaceutical product is defined as “the capability 
of particular formulation to remain within its physical, chemical, 
microbiological, therapeutic and toxicological specification” (21). 
Several factors affect the stability of pharmaceutical products, 
including the stability of active ingredients, the potential interaction 
between the active ingredient and the excipients, the process of 
manufacturing, the dosage form, the container liner-closure system, 
the environmental conditions encountered during shipping, storing, 
handling the drug and the time between manufacture and usage (21). 
 Chemical degradation of the active constituent in a 
pharmaceutical product often results in loss of potency. The rate of 
chemical reaction of a drug or excepient in a medicine may be 
affected by: pH, general acids and bases, ionic strength, nature of 
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solvent, drug concentration, surfactants, moisture, temperature, light, 
ionizing radiation and mechanical processes (21). 
 Physical changes may result in diminished bioavailability and 
efficacy or adversely affect other properties such as dispersability, 
acceptability to the patient and convenience of use (21).  
 During manufacturing, dispensing, storage or use of the drug, 
there is a high possibility of its contamination with mold, yeasts or 
bacteria. Contamination may also be possible from packaging 
materials, premises, equipments, workers and the atmosphere (21). 
1.7. Chemical analysis 
Chemical analysis gives information about the chemical 
composition of a substance, its purity, content and presence or 
absence of impurities. Instrumental analysis is now the most 
commonly used type of analysis, and is also applied in all areas for 
pure and applied sciences. One instrument or several instruments can 
be used to solve an analytical problem (21). 
1.7.1. Definitions 
Analytical technique: is a fundamental scientific phenomenon 
that has proved useful for providing information on the composition 
of substances. e.g. Ultra-violet Spectrophotometry is an analytical 
technique. 
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Analytical method: is a specific application of a technique to 
solve an analytical problem. It can be called as instrumental method. 
e.g., The UV spectrophotometric analysis of a dye mixture is an 
example of an analytical method. 
Procedure: is the set of instructions formulated for carrying out 
a method. It lists out the steps to be followed for the analysis. e.g. the 
dye mixture is dissolved in water and the absorbance was read at 
different wavelengths to obtain the concentration of different dyes 
mixed together. 
Protocol: is the most specific description of a method. The 
detailed directions must be followed without exception.  
Precision: is a term which could be defined as the degree of 
agreement between different values obtained under substantially the 
same experimental conditions. 
Accuracy: may be defined as the agreement of a measurement 
with the known true value for the quantity being measured (22). 
1.7.2. Types of instrumental analysis 
 Most instrumental techniques are derived from three main 
classes: 
1.7.2.1. Spectroscopic techniques which include: ultraviolet and 
visible spectrophotometry, fluorescence and 
phosphorescence spectrophotometry, atomic 
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spectrophotometry (Emission and Absorption), infrared 
spectrophotometry, Raman spectroscopy, and X-ray 
spectroscopy. 
1.7.2.2. Electrochemical techniques and they include: 
conductometry, potentiometry, coulometry, stripping 
techniques, and voltammetry 
1.7.2.3. Chromatographic Techniques, these include: gas 
chromatography (GC), thin Layer chromatography (TLC), 
Supercritical Fluid Chromatography (SFC) and High 
Performance liquid chromatography (HPLC) (23). 
 Properties which could be measured by Instrumental techniques: 
1.  Mass: measured by gravimetry. 
2. Volume: measured by volumetry. 
3. Electrical quantity: e.g: current, potential conductors, and 
amperometry, measured by electrical potential, conductometry and 
potentiometry. 
4. Absorption of radiation: measured by UV, Visible, IR 
Spectrophotometry and AAS (Atomic absorption Spectrophotometry). 
5. Emission of radiation: measured by Emission spectroscopy 
and flame photometry. 
6. Scattering and transmission of radiation: measured by 
Nephelometry, Turbidimetry (23). 
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1.7.3. Selection of an analytical technique 
Selection of the analytical technique to analyze a substance 
depends on the property to be analyzed, taking in consideration the 
concentration of the sample and accuracy (22). 
1.7.4. Advantages of Instrumental Analysis 
· Small amounts of samples are enough to run the analysis. 
· Reliable results are obtained. 
· All types of samples including complex ones can also be 
analyzed. 
· They can be automated. 
· Shorter time is needed for determination of samples (22, 23). 
 1.7.5. Limitations of Instrumental Analysis 
· Each instrument has its own accuracy and sensitivity; they 
vary with the type of the instrument.  
· Most instruments are relatively expensive. 
· The linearity range to be measured is limited. 
· Training on how to use the instrument is needed for proper use 
particularly for sophisticated instruments. 
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· Relatively large space is needed. 
· Power supply must be continuous without fluctuations. (22, 
23) 
1.7.2.1. Spectrophotometry  
The science that deals with the quantitative study of 
electromagnetic spectra is known as spectrophotometry. It deals with 
visible light, near- ultraviolet, and near- infrared. The instrument used 
is called a spectrophotometer. A spectrophotometer “is a photometer 
(a device for measuring light intensity) that can measure intensity as a 
function of the color, or more specifically, the wavelength of light” 
(22). 
Measurement of light absorption is probably the most common 
application of spectrophotometers. Single beam and double beam are 
the two main classes of spectrophotometers; the feature applied here is 
the measurement of light absorption. A single beam 
spectrophotometer measures the absolute light intensity, where the 
double beam spectrophotometer measures the ratio between light 
intensity in two different light paths (22). 
Spectroscopic methods can be classified according to the nature 
of their interaction with light. A substance can either absorb the 
electromagnetic spectra, giving rise to absorption spectroscopy. A 
substance can also radiate (emit) the electromagnetic spectra, giving 
rise to emission spectroscopy. Another main feature that measures the 
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amount of the light scattered by a substance at a certain wavelength, 
polarization angles and incident angles giving rise to Scattering 
spectroscopy. Raman spectroscopy is now considered one of the most 
useful applications of light scattering spectroscopy (22). 
There are five basic components in any instrument that 
measures light absorption, emission or transmission; a stable light 
source, monochromator, sample containers for sample and solvent, 
radiation detector, and a signal indicator (22). 
1.7.2.2. Electrochemical Techniques 
 Titration is the determination of the amount or concentration of 
a sample by adding a known quantity of a substance of known 
concentration, with which it reacts according to a definite known 
reaction, the end point is indicated by visual change, for example 
color change or appearance of a precipitate.  
The end point may also be detected electrically and according 
to the electrical quantity measured, titrations may be classified into: 
1. Potentiometric titrations which involves measurement of the 
potential difference between two electrodes of a suitable 
cell. 
2.  Conductometric titrations, the electrical conductance or 
resistance of the solution being titrated is being measured (22). 
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1.7.2.3. Chromatographic techniques 
 Chromatography was first invented for the separation of 
colored substances into individual components. Along with time the 
technique has been modified dramatically; nowadays various types of 
chromatographic techniques and instruments are used to separate 
almost any sample whether one component or mixture, colored or 
even colorless, and to test the purity of each component. 
Basically, chromatographic technique is based on the difference 
in the rate at which the components of a mixture move through the 
stationary phase under the influence of the mobile phase. 
According to the nature of the stationary and mobile phases, 
chromatography can be classified into: 
1. Partition Chromatography: the stationary and mobile phases are 
liquids and the samples are separated as its components elute 
according to their partition coefficients. 
2.  Adsorption Chromatography: In this the stationary phase is a 
solid, e.g., silica gel, alumina etc. based on the affinity of the 
solutes to stationary and mobile phases, they elute in order of 
their adsorption coefficients, when passing suitable solvents 
through the column. 
Paper chromatography can be considered a special case of 
partition/ adsorption chromatography in which the adsorbent column 
is a paper strip. 
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3.  Gas Chromatography: here the mobile phase is a mixture of 
gases; it is also called vapor phase chromatography (VPC) (22). 
Basically gas chromatography is a separation technique in 
which the samples are vaporized, separated and fractionated due to the 
partitioning between the gaseous mobile phase and the stationary 
phase held in column. GC has the advantage that it separates mixtures 
even in low concentrations. On the other hand compounds with low 
vapor pressure and compounds which are unstable at elevated 
temperatures can’t be analyzed using GC. Here the advantage of 
HPLC appears, which is a liquid chromatography using solid 
absorbents under high pressure (22). 
Supercritical fluid chromatography (SFC) provides a useful 
alternative to gas chromatography and liquid chromatography for 
some samples. The mobile phase in supercritical fluid 
chromatography is a gas held at a temperature and pressure exceeding 
its critical point. Under these conditions the mobile phase is neither a 
gas nor a liquid. Instead, the mobile phase is a supercritical fluid 
whose properties are intermediate between those of a gas and a liquid. 
Specifically, supercritical fluids have viscosities that are similar to 
those of gases, which means that they can move through either 
capillary or packed columns without the need for the high pressures 
encountered in HPLC (22). 
 Most HPLC devices consist of a pump which takes up the 
solvent at a constant pressure (4500 psi) and lesser flow rates (few 
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ml/min). The solvent is then fed to a rotary valve, to which a sample 
loop is attached; a micro syringe is used to inject the sample. The 
solvent then travels through the column to the detector, the final 
results are displayed on the recorder which is normally a computer 
device. The choice of the mobile phase components determines the 
efficiency of separation in HPLC (23).  
The rise of HPLC to the most widely used instrumental 
analytical systems originates in part from the broad variety of 
selectivities introduced by the enormous number of stationary phases 
available and the easy adjustment of selectivity by changing the 
composition of the mobile phase. The classical separation systems 
based on pure silica or alumina—now called normal phase 
chromatography—with nonpolar mobile phases would not have 
provided the variety and the simplicity of separation methods, and the 
reproducibility. The availability of the so-called reversed phases (RPs) 
based on chemically modified silica, opened for HPLC direct access 
to aqueous, and hence, bioanalytical systems. These phases are the 
workhorses in HPLC. Their diversity allows us to select appropriate 
columns for a wide variety of applications ranging from separations of 
aromatic hydrocarbons, pharmaceuticals, and pesticides to 
applications in bioanalysis. All commonly used RP are based on 
silica. Their selectivity and efficiency depend on the physical and 
chemical properties of the base material silica and on the type and 
means of bonding of the alkyl groups for RP systems (23). 
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Many different physical features have been examined to be 
used as chromatography detectors; but four types of detectors are most 
commonly used: ultraviolet (UV) absorbance, refractive index (RI), 
fluorescence, and conductivity detectors. Nowadays, these detectors 
make up about 80% of the used detectors. Never the less new detector 
such as the laser-induced fluorescence (LIF), electrochemical (EC), 
evaporative light scattering (ELS), and mass spectrometer (MS) 
detectors have been developed to meet the demands set by either 
specialized analyses or by miniaturization (23). 
1.7.2.3.1. Advantages of HPLC 
1. HPLC is an automated process, fast, reproducible and easy to 
operate. (24). 
2. Requires relatively small samples (25) 
3. A well-developed HPLC method can be very efficient, allowing 
the operator to test for numerous analytes in one "run" of an 
unknown sample (25). 
4. HPLC is a nondestructive test and samples can sometimes be 
recovered after analysis (25). 
1.7.2.3.2. Disadvantages of HPLC 
1. It is difficult to detect co-elution (24, 25). 
2. There is a high cost for equipment needed to conduct HPLC 
(24, 26).  
3. Its operation can be complex, requiring a trained technician to 
operate (24, 25). 
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4. Because of the speed of the process, the equipment has low 
sensitivity to some compounds (24). 
5. The detection methods generally used (UV light absorbance or 
refractive index change) are nonspecific, meaning the detector 
will respond to chemicals other than the ones being tested for 
(25). 
HPLC is probably the most universal type of analytical procedure; 
its application areas include quality control, process control, forensic 
analysis, environmental monitoring and clinical testing. In addition 
HPLC also ranks as one of the most sensitive analytical procedures 
and is unique in that it easily copes with multi-component mixtures. It 
has achieved this position as a result of the constant evolution of the 
equipment used in LC to provide higher and higher efficiencies at 
faster and faster analysis times with a constant incorporation of new 
highly selective column packings (27). 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
Ϯϰ 
 
1.8. Aim of the research  
The assay of pharmaceutical preparations containing more than 
one active ingredient often represents difficulties that face analysts. 
Methods that allow the easy determination of each ingredient in 
presence of the others are needed. Such methods should be selective, 
sensitive, easy to perform and not costly. 
Development of a simple, easy to conduct and economical 
method for the assay of drug combinations in pharmaceutical 
formulations is generally a troublesome work. Developing of such a 
method will have the significance of solving the problem and help in 
the easy assay of drug combinations in pharmaceutical formulations. 
The present work presents the development, optimization, 
validation and application of an HPLC method for the assay of 
dexamethasone sodium phosphate and chloramphenicol in eye drops 
preparations, an HPLC method for the assay of dorzolamide 
hydrochloride and timolol maleate in eye drops preparations and 
HPLC method for the assay of antazoline hydrochloride and 
tetrahydrozoline hydrochloride in eye drops preparations. 
Also the methods are considered a contribution in drug 
combination analysis. The robustness, ruggedness and stability 
indicating properties make the developed methods suitable for routine 
analysis of these combinations. There is no pharmacopoeial method 
for the assay of the combination of dexamethasone sodium phosphate 
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– chloramphenicol, dorzolamide hydrochloride – timolol maleate and 
antazoline hydrochloride – tetrahydrozoline hydrochloride. From the 
results obtained in the present work it is suggested that the three 
developed methods can be subjected to collaborative studies to 
evaluate their suitability as pharmacopoeial methods for the assay of 
these combinations. 
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2.1. Instrumentation 
2.1.1. Four decimals sensitive balance (SHIMADZU) was used to 
weigh all the materials. 
2.1.2. HPLC was performed on two devices: 
2.1.2.1. KNAUER HPLC system software ChromGateTM; the 
column used was Eurospher 100 C-18 25*4.6 (5µm). The detector 
was UV, model K-2501 set at 275nm. Injection volume was 20 µl and 
the pump was K-120/501. 
2.1.2.2. Shimadzu Prominence HPLC system; the injector was 
P/N 7725i, 20µL loop, DGU-20A3 prominence degasser, LC-20 AB 
pump, shimpack VP-ODS (250L×4.6) column, and a SPD-20A 
prominence UV/VIS detector. 
2.1.3. Knick DIGITAL-pH-METER. 
2.1.4. Decon, FS200b for ultrasonication. 
2.2. Materials 
2.2.1. Reference materials 
2.2.1.1. Dexamethasone sodium phosphate and chloramphenicol 
reference materials were received from the Central Medical Supplies, 
Khartoum, Sudan. The reference materials were used as received 
without further treatment. 
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2.2.1.2. Timolol maleate (manufactured by M/s Lavallee, France, 
99.9% purity) and dorzolamide hydrochloride (manufactured by M/s 
Elkton, VA Virginia, USA, and 99.9% purity) were purchased from 
Peshawar, Pakistan, and were used as received without further 
treatment. 
2.2.1.3. Antazoline sulphate (manufactured by M/s Topharman 
Shanghai, China, and 99.92% purity) and tetrahydrozoline 
hydrochloride (manufactured by M/s Societa Italiana Medicinali 
Scandi Sbabiliment Chimico farmaceutici Industriali, Flarence, Italy, 
and 100.2%) were purchased from Peshawar, Pakistan, and were used 
as received without further treatment. 
2.2.2. Formulations selected to be analyzed 
2.2.2.1. Spersadex comp® (Dexamethasone sodium Phosphate, 
chloramphenicol) was purchased from local pharmacies in Khartoum, 
Sudan. 
Manufacturer: Novartis, Netherland 
Batch number: 417196 
Manufacturing date: 01/2010 
Expiry date: 12/2011 
2.2.2.2. XolamolTM  solution (dorzolamide hydrochloride and timolol 
maleate) purchased from local pharmacies in Khartoum, Sudan. 
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Manufacturer:  Jamjoom Pharma, Kingdom of Saudi Arabia 
Batch number: LB002 
Manufacturing date: 02/2010 
Expiry date: 02/2012 
2.2.2.3. Apillerg (antazoline hydrochloride and tetrahydrozoline 
hydrochloride) purchased from local pharmacies in Khartoum, Sudan. 
Manufacturer: Amman Pharmaceutical Industries CO. LTD, Jordan 
Batch number: EW102 
Manufacturing date: 05/2010 
Expiry date: 05/2013 
2.2.2.4. OptizolinTM (antazoline hydrochloride and tetrahydrozoline 
hydrochloride) purchased from local pharmacies in Khartoum, Sudan. 
Manufacturer:  Jamjoom Pharma, Kingdom of Saudi Arabia 
Batch number: KE002 
Manufacturing date: 05/2009 
Expiry date: 05/2011 
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2.2.3. Materials used to prepare mobile phase: 
Acetonitrile and methanol were of HPLC grade (Scharlau, 
India). All other chemicals were analytical grade reagents:  
Glacial acetic acid Scharlau, India 
Sodium acetate MERCK, Darmastadt 
Potassium dihydrogen phosphate Chim. Pure, DAB 
Ammonia BDH chemicals, England 
Orthophosphoric acid BDH chemicals, England 
Tetrahydrofuran MERCK, Darmastadt 
2.3. Chromatographic parameters 
 Peak symmetry, resolution and other chromatographic 
parameters were calculated using the following formula. 
Rs = ଶሺ௧మି ௧భሻ
ௐభାௐమ
  
Where Rs is the resolution factor, t1 and t2 are the retention time of 
first and second adjacent bands, whereas W1 and W2 are there baseline 
band width (28). 
K’ = ௧ೃି ௧బ
௧బ
 
Where K’ is the capacity factor, tR is the retention time of the peak, 
whereas t0 is the time for the unretained peak (28). 
Symmetry = ௕
௔
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Where a is the peak front at 10% of the peak height to peak maxima, 
whereas b is the peak maxima to peak end at 10% of the peak height 
(28). 
2.4.1. Analysis of Spersadex comp.® 
2.4.1.1. Preparation of solutions: 
(a) -Dexamethasone sodium phosphate stock solution: 
Dexamethasone sodium phosphate (0.01g) was accurately weighed 
and transferred into a 25-ml volumetric flask, dissolved in 10ml water 
then volume completed with water. 
- Chloramphenicol stock solution: 
Chloramphenicol (0.025g) was accurately weighed and transferred 
into a 50-ml volumetric flask, dissolved in 40ml water using 
ultrasonication before volume completion. 
(b) Mixed standard working solutions 
     Four serial dilutions were prepared by transferring 1, 2, 3, 4ml 
volumes of the standard stock of dexamethasone sodium phosphate 
into 25-ml volumetric flasks, followed by addition of 5,10,15,20ml 
volumes of the chloramphenicol stock solution and the volume was 
completed to 25 with water. The standard mixture was prepared in the 
ratio of 1:5 dexamethasone sodium phosphate to chloramphenicol. 
This simulates the ratio of both in the eye drops. 
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(c) Preparation of the sample 
     One ml of the eye drops was accurately delivered into 25-ml 
volumetric flask, and the volume was completed with water. 
2.4.1.2. Precision 
Six replicate measurements were made by using the following 
solutions in the mobile phase: (i) 40µg of dexamethasone per ml, and 
(ii) 200µg of chloramphenicol per ml. 
2.4.1.3. Linearity 
Four different concentrations of dexamethasone sodium phosphate, 
and chloramphenicol were prepared in water; 20 µL of each 
concentration was injected. 
2.4.1.4. Limit of detection 
Limit of detection and limit of quantification were calculated 
from calibration curve results using the following formulas: 
Sy/x = ඨσ൫ܻ െ݅z݅൯
ଶ
െ݊ʹ
 
Sb = 
ௌ௬Ȁ௫
ξσሺ௑௜ି௑ሻమ
 
Sa = Sy/x ξ
σ௑௜మ
௡σሺ௑௜ି௑ሻమ
 
L.O.D = ଷǤଷൈௌ௔
௕
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L.O.Q = ଵ଴ൈௌ௔
௕
           
where Sa is the standard deviation for the intercept, b is the slope (29). 
2.4.2. Analysis of XolamolTM 
2.4.2.1. Preparation of solutions: 
(a)-Timolol maleate stock solution: 
Timolol maleate (0.05 g) was accurately weighed and 
transferred into a 50-ml volumetric flask, dissolved in about 30 ml 
water, then volume completed with water. 
    -Dorzolamide hydrochloride stock solution:  
Dorzolamide hydrochloride (0.15g) was accurately weighed 
and transferred into a 50-ml volumetric flask, dissolved in about 30 ml 
and the volume completed with water. 
(b) Mixed standard working solutions: 
 Four serial dilutions were prepared by transferring aliquots of 
3, 6, 9,12ml of the standard stock solution of both timolol maleate and 
dorzolamide hydrochloride into 25-ml volumetric flasks. The volume 
was completed with water.  
The standard mixture was prepared in the ratio of 1:3 timolol 
maleate to dorzolamide hydrochloride, to simulate the ratio of both in 
the eye drops. 
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(c)Preparation of the sample: 
One ml of the eye drops was accurately delivered into 25-ml 
volumetric flask, and the volume completed with water. 
2.4.2.2. Precision 
Six replicate measurements were made by using the following 
solutions in water: (i) 136.8 µg of timolol maleate per ml, and (ii) 
445.2µg of dorzolamide hydrochloride per ml. they were injected 
separately. 
2.4.2.3. Linearity 
Four different concentrations of timolol maleate, and 
dorzolamide hydrochloride were prepared in water; 20 µl of each 
concentration was injected into the HPLC column, many calibration 
curves were constructed and from which results for linearity were 
calculated (29). 
2.4.2.4. Limit of detection and limit of quantification 
Limit of detection and limit of quantification were calculated 
from calibration curve results using the formulas mentioned in 2.4.1.4.  
2.4.2.5. Assay 
 Triplicate samples of each of the mixed standard working 
solutions (b) were analyzed by HPLC. Calibration curves for each of 
timolol maleate and dorzolamide hydrochloride were constructed 
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using peak area and peak height against the corresponding 
concentration of each drug. The calibration curves were used for the 
assay of the drugs. 
2.4.3. Analysis of Apillerg and OptizolinTM 
2.4.3.1. Preparation of solutions 
(a) - Tetrahydrozoline hydrochloride stock solution 
Tetrahydrozoline hydrochloride (0.0150 g) was accurately 
weighed and transferred into a 50-ml volumetric flask, 
dissolved in about 20 ml water, then volume was completed 
with water. 
-Antazoline sulphate stock solution 
Antazoline sulphate (0.0250g) was accurately weighed and 
transferred into a 50-ml volumetric flask, dissolved in about 20 
ml water, then volume was completed with water. 
-Sulphamethoxazole stock solution (internal standard) 
Sulphamethoxazole (0.0200g) was accurately weighed, 
dissolved with 5 ml acetonitrile, transferred into 50-ml 
volumetric flask, and the volume was completed with the 
mobile phase. 
(b) Mixed standard working solutions: 
Five serial dilutions were prepared by transferring aliquots of 1, 
2, 2.4, 3, 4ml of the standard stock solution of antazoline 
sulphate into 25-ml volumetric flasks, followed by the addition 
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of 1, 2, 2.6, 3, 4ml of the standard stock solution of 
tetrahydrozoline, addition of 4ml of the standard 
sulphamethoxazole internal standard stock solution, then the 
volume was completed with water. 
The standard mixtures were prepared in a ratio 1.2:1 to simulate 
their ratio in the eye drops formulation. 
(c) Preparation of the sample 
Two ml of the eye drops was accurately delivered into 25-ml 
volumetric flask, followed by the addition of 4ml of internal 
standard and the volume completed was with water. 
2.4.3.2. Calibration curve 
Five different concentrations were prepared (mixed standard 
working solutions (b)). Triplicate 20µl volumes of each solution were 
injected into the column. A plot of the peak area-ratio or peak height 
ratio of each concentration to the internal standard against the 
corresponding standard concentration was done to obtain the 
calibration graphs. 
2.4.3.3. Mobile phase polarity index calculation 
Polarity index (P’abc) for the systems used were calculated using 
the following formula: 
P’abc = ? a + ? b + ? c 
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Where ?  is the polarity index of the solvent, a is the fraction of 
acetonitrile, b is fraction of THF, and c is fraction of aqueous phase 
(30). 
2.4.3.4. Precision 
 Between-days and within-day precisions were determined for 
three different concentrations at low, medium and high levels of the 
standard curve. The relative standard deviation (RSD) values were 
calculated. 
2.4.3.5. Limit of detection and limit of quantification 
Limit of detection and limit of quantification for both drugs were 
calculated from calibration curve results using the formulas mentioned 
in 2.4.1.4. 
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Chapter 3 
Results and discussion 
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3.1. Dexamethasone sodium phosphate and chloramphenicol 
 From a clinical point of view, drug combinations are intended 
to give synergistic effect or to cover a wide range of therapeutic 
effect. For pharmaceutical analysts, the proper drug quality assurance 
is the target. A safe, active drug free from impurities is needed. This is 
achieved through proper quality control monitoring to ensure the right 
concentration of an intact drug among other measures.  
As most of drugs molecules carry both a non-polar and polar 
moieties, reversed phase systems are usually used in their analysis. 
The easily controlled composition of mobile phase mixture (non-polar 
+ polar solvents, buffered and non-buffered) through isocratic or 
gradient system, allows a number of drug combinations to be well 
resolved.  
In the present study an HPLC method for the simultaneous 
determination of dexamethasone sodium phosphate and 
chloramphenicol combination is presented. The study also covered 
investigation of the suitability of the USP (HPLC) method described 
for the determination of dexamethasone sodium phosphate in 
injections, for the assay of this combination. A discussion of the work 
reported by Iqbal et. al, for the assay of the combination is also 
presented. 
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3.1.1. Selection of the mobile phase 
 In the present study separation was carried out under isocratic 
conditions. Accordingly, and in order to affect the simultaneous 
elution of the two components under isocratic conditions, factors like 
organic component, flow rate and pH were investigated. Table 1 
illustrates the results of the preliminary trials carried out to optimize 
the chromatographic conditions which can give satisfactory resolution 
for the two drugs. 
The assessment of good separation was judged from good 
capacity factor, peak symmetry and resolution factor with 
reproducible retention time. These criteria were obtained when using a 
36:64v/v acetonitrile: 5% v/v aqueous glacial acetic acid, at a flow 
rate of 1.5 ml/min. The elution order was dexamethasone sodium 
phosphate at 2.23min, (K value 1.23) and chloramphenicol at 
3.47min, (K value 2.47). 
 For all the systems used, chloramphenicol showed always good 
peak characteristics. On the other hand, dexamethasone sodium 
phosphate peak showed either tailing or elution at solvent front. To 
overcome these problems, different mobile phase mixtures or pH 
adjustments, using sodium acetate or increase in glacial acetic acid 
strength (1%, 3%, and 5%) v/v, were tried. Glacial acetic acid at the 
percentages tried gave promising results. The use of 1%, 3%, and 5% 
glacial acetic acid at a flow rate of 1.5 ml/min in a ratio of 36:64 %v/v 
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lead to a shift of the dexamethasone sodium phosphate peak away 
from the solvent front (for 1%v/v glacial acetic acid RT was 1.8, (K’ 
0.89); for 3% v/v  RT was 2.1, (K’ 1.21); and for 5% v/v RT was 2.23, 
(K 1.23)) (Fig 1,2,3).  
 
 
 
 
 
Figure 1: chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops using acetonitrile: 1% v/v glacial acetic 
acid (36:64 v/v) mobile phase 
 
 
Re
sp
on
se
 (m
Vo
lt)
 
Time (minutes) 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
ϰϮ 
 
 
Figure 2: chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops using acetonitrile: 3% v/v glacial acetic 
acid (36:64 v/v) mobile phase 
 
 
 
Figure 3: Chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops (solution c) using acetonitrile:5%v/v 
glacial acetic acid (36:64 v/v) mobile phase 
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 On the other hand chloramphenicol peak showed a decrease in 
capacity factor from 3.02 to 2.89 to 2.47 when changing the strength 
of aqueous glacial acetic acid from 1%, to 3% and then to 5%v/v 
respectively. The increase in capacity factor for dexamethasone 
sodium phosphate and its decrease for chloramphenicol did not affect 
the good resolution between them but it lead to a short time of 
analysis for the mixture (Fig. 3). 
3.1.2. Precision 
 The effect of the matrix present in the eye drops on the assay 
results was checked by the recovery addition method. The results 
showed good recovery: 99.60±0.78 n=3 for dexamethasone sodium 
phosphate (added concentration was 20µg/ml) and 100.78±0.92 n=3 
for chloramphenicol (added concentration was 100µg/ml). These 
results show clearly that the matrix did not affect the results obtained 
by the present assay method i.e. there was no interference from the 
substance(s) present in the matrix. 
3.1.3. Linearity:  
 A calibration curve was prepared using mixtures standards of 
the drugs in a concentration range of 16-64 µg/ml for dexamethasone 
sodium phosphate and 80-320 µg/ml for chloramphenicol. The 
correlation coefficient values (r) obtained for dexamethasone sodium 
phosphate (0.994) and for chloramphenicol (0.9995) indicated good 
distribution of points along the linearity range. 
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 The developed method was applied for the determination of 
these compounds in eye drops formulation marketed in Sudan 
(Spersadex comp.®) which contains dexamethasone sodium phosphate 
and chloramphenicol in a ratio of 1:5. 
 Dexamethasone sodium phosphate is a weak UV-absorbing 
steroid with ? max at about 240nm. On the other hand chloramphenicol 
is a good UV-absorbing compound with ? max at about 278nm. The 
assay was carried out at 240nm which favors better response for the 
dexamethasone sodium phosphate without having a great effect on the 
chloramphenicol which is found in a large concentration. 
 It was, interestingly, observed that dexamethasone sodium 
phosphate peak, at its retention time of 2.23min, disappeared when the 
solution of the drops (solution c) was left for seven days. One the 
other hand, another peak appeared at a retention time of more than 8 
min (Fig. 4). This observation was confirmed by analysis of a number 
of solutions of the drug; fresh and after being left for seven days. This 
phenomenon was attributed to the possible change of the polar 
dexamethasone sodium phosphate to the non-polar dexamethasone 
which is retained to a greater extent (31). 
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Figure 4: Chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops (solution c) left for seven days 
 The stability of the eye drops constituents in their original 
packing was assessed by exposure to sunlight for one day or after 
being left at room temperature for seven days. No change of 
concentration or change of retention times was observed. 
3.1.4. Assay 
 Both peak areas and peak heights were utilized in the 
determination of the analytes concentration. For chloramphenicol both 
peak areas and heights gave satisfactory results. For dexamethasone 
sodium phosphate peak heights gave more accurate and precise results 
(Table 2). 
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Table 2: Comparison of the results of the assay of Spersadex comp. ® 
obtained by the developed method and the USP method 
Drug developed method USP method 
Area Height Area Height 
Dexamethasone 
sodium phosphate 
99.52±1.16 
n= 6 
99.85±1.36 
n= 6 
98.81±1.69 
n= 6 
100.67±0.89 
n= 6 
Chloramphenicol 99.40 ±1.79 
n= 6 
100.06±1.72 
n= 6 
99.93±1.31 
n= 6 
100.43±1.14 
n= 6 
 
 The literature study revealed one HPLC method reported to be 
used for the assay of the combination of dexamethasone sodium 
phosphate and chloramphenicol in eye drops (5). The method 
employed a Shim-Pack CLC-ODS column (6.0 * 150 mm2). The 
mobile phase was composed of a mixture of the buffer solution, 
acetonitrile and methanol mixed in the ratio of 1.73:1.16:1, at a flow 
rate of 0.5ml/min, at 50? C, and detection at 254nm. A number of 
reservations about the conditions used in the method reported by Iqbal 
and co-workers (5) must be stated. The mobile phase ratio 1.73:1.16:1 
i.e. (44.47%:29.82%:25.01%v/v) for the buffer, acetonitrile and 
methanol respectively seems rather critical. The robustness of the 
method could therefore be easily and significantly affected. The non-
completely resolved peaks of dexamethasone sodium phosphate and 
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chloramphenicol are liable to undergo more overlapping with slight 
errors and/or alterations in these ratios or even if the buffer ionic 
strength was changed. The authors (5) claimed a resolution factor of 
1.5 between dexamethasone sodium phosphate and chloramphenicol. 
However, and as can be seen from the published chromatogram, the 
actual resolution factor in the work presented by these authors appears 
to be more than 1.25 and less than 1.5. It is known that for 100% 
resolution (peaks reaching the baseline) the resolution factor is not 
less than 1.5. This ensures more than 99.87% accuracy in the assay 
results of closely eluting compounds of about the same height (31, 
32). The temperature used in the reported method (50? C) did improve 
the peak shape for dexamethasone and dexamethasone sodium 
phosphate, most probably through increasing their distribution 
coefficient in the mobile phase relative to that in the stationary phase. 
However, this is yet another factor for reducing resolution between 
closely eluting peaks. 
 The USP describes an HPLC method for the determination of 
dexamethasone sodium phosphate in injection formulations. It was 
deemed interesting to test this USP method for the possibility of 
separation of chloramphenicol in presence of dexamethasone sodium 
phosphate. Excellent resolution was obtained. The elution order was 
chloramphenicol (retention time 3.18min) and dexamethasone sodium 
phosphate (retention time 6.617min) (Fig. 5). 
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Figure 5: Chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops (solution c) using the USP method. 
 
 The USP method was used for the assay of the drugs in the 
combination and subsequently utilized for validation of the method 
reported in the present work. Using the USP method, calibration 
curves gave   correlation coefficients of more than 0.99 for 
dexamethasone sodium phosphate and more than 0.997 for 
chloramphenicol, using both peak areas and heights. The results of the 
assay of the combination using the present method and the USP 
method are compared (Table 2). The t value and F value were 
calculated to validate accuracy and precision of the method compared 
to the USP method. 
 The solutions (c) of the drops containing dexamethasone 
sodium phosphate and chloramphenicol, kept for seven days, were 
analyzed using the USP system. Similar shift of the dexamethasone 
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sodium phosphate peak was observed (Fig. 6). Spiking this solution 
with fresh dexamethasone sodium phosphate showed three peaks: for 
dexamethasone sodium phosphate, chloramphenicol, and 
dexamethasone (Fig. 7). 
 
Figure 6: Chromatogram of dexamethasone sodium phosphate and 
chloramphenicol eye drops (solution c) left for seven days, using the 
USP method 
 
 
Figure 7: Chromatogram of the solution (Fig. 6) spiked with fresh 
dexamethasone sodium phosphate 
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The validity of the present method was assessed using the 
official USP method. The results obtained (Table 3) showed no 
significant difference in accuracy and precision between the two 
methods. 
Table 3: The calculated t and F values compared to the tabulated 
values for the developed method for the analysis of dexamethasone 
sodium phosphate and chloramphenicol 
Drug                t-values            F-values 
Using area Using 
height 
Using area Using 
height 
Dexamethasone 
sodium 
phosphate 
0.85(cal.) 
2.23(tab.) 
1.24 (cal.) 
2.23(tab.) 
2.12 (cal.) 
5.05(tab.) 
2.34(cal.) 
5.05(tab.) 
Chloramphenicol  0.52(cal.) 
2.23(tab.) 
0.44 (cal.) 
2.23(tab.) 
1.87 (cal.) 
5.05(tab.) 
2.26 (cal.) 
5.05(tab.) 
 
 The present method, the USP method, and the method reported 
by Iqbal et. al. can all be considered as stability indicating methods for 
dexamethasone sodium phosphate if dexamethasone (as a base) is 
present as an impurity. The present developed method and the USP 
method are expected to be stability indicating for chloramphenicol. 
This is because chloramphenicol can undergo hydrolysis to 2-amino-
1-(4-nitrophenyl)-propane-1, 3-diol which is more polar than 
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chloramphenicol and is expected to elute before it. The diol hydrolytic 
product would also elute after dexamethasone sodium phosphate 
which, as a salt, is very polar (23). In the method reported by Iqbal 
and co-workers, interference of the hydrolysis product(s) is most 
likely to occur rendering the method doubtful for use as a stability 
indicating method. 
 In another reported HPLC method for the quantification of this 
combination (6), the mobile phase used was methanol 0.05mol/L 
potassium dihydrogen phosphate (55:45). The use of phosphate buffer 
may possibly mask dexamethasone if present as an impurity or as a 
degradation product. 
3.1.5. Limit of detection and limit of quantification 
The limits of detection and limits of quantification were 
calculated from the calibration curve results and were found to be 
1.85µg/ml and 5.61µg/ml for dexamethasone sodium phosphate. The 
corresponding values for chloramphenicol were 4.516µg/ml and 
13.685µg/ml respectively. These low levels indicate that the method is 
sensitive and suitable for the determination of dexamethasone sodium 
phosphate and chloramphenicol if present in combinations. Tables 4 
and 5 describe the steps used to calculate the limits of detection and 
limit of quantification. 
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Table 4: Calculation of limits of detection and limit of quantification 
for dexamethasone sodium phosphate 
Xi Xi2
  
Yi Ýi (Yi   Ýi)2 (Xi -X¯)2 
16 256 65497022 65886286.5 1.515268×1011 576 
32 1024 128326465 128806241 2.301591×1011 64 
48 2304 193853433 191726141.5 4.525369×1012 64 
64 4096 253387791 254646069 1.583264×1012 576 
 ? =  
7680 
  ? = 
6.490318×1012 
? = 
1280 
r = 0.9998  a = 2966359  b = 3932495.469 
Sy/x = ට଺Ǥସଽ଴ଷଵ଼ൈଵ଴
భమ
ଶ
   = 1801432.486 
Sb = 
ଵ଼଴ଵସଷଶǤସ଼଺
ξଵଶ଼଴
  = 50351.568 
Sa = 1801432.486× ට
଻଺଼଴
ସൈଵଶ଼଴
 = 2206295.198 
L.O.D. = ଷǤଷൈଶଶ଴଺ଶଽହǤଵଽ଼
ଷଽଽଶସଽହǤସ଺ଽ
 = 1.85µg/ml 
L.O.Q. = ଵ଴ൈଶଶ଴଺ଶଽହǤଵଽ଼
ଷଽଽଶସଽହǤସ଺ଽ
 5.61µg/ml 
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Table 5: Calculation of limits of detection and limit of quantification 
for chloramphenicol 
Xi Xi2  Yi Ýi (Yi   Ýi)2 (Xi -X¯)2 
80 6400 157222509 159500236.9 5.188044×1012 14400 
160 25600 289435988 292391615 8.735731×1012 1600 
240 57600 434383066 436977721.3 6.732236×1012 1600 
320 102400 548841106 555441097.6 4.355989×1013 14400 
 
? = 
192000   
? = 
64.215901×1012 
? = 
30000 
r = 0.9990  a = 27519950  b = 1649753.586 
Sy/x = ට଺ସǤଶଵହଽ଴ଵൈଵ଴
భమ
ଶ
   = 1791869.15 
Sb = 
ଵ଻ଽଵ଼଺ଽǤଵହ
ξଷ଴଴଴଴
  = 10345.366 
Sa = 1791869.15 × ට
ଵଽଶ଴଴଴
ସൈଷ଴଴଴଴
 = 2257755.129 
L.O.D. = ଷǤଷൈଶଶହ଻଻ହହǤଵଶଽ
ଵ଺ସଽ଻ହଷǤହ଼଺
 = 4.516µg/ml 
L.O.Q. = ଵ଴ൈଶଶହ଻଻ହହǤଵଶଽ
ଵ଺ସଽ଻ହଷǤହ଼଺
  = 13.685µg/ml 
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The result of this study is published at International Journal of 
Chemical Sciences and Technology, issue April 2011 (33) (see 
appendix). 
3.2. Timolol maleate and dorzolamide hydrochloride 
 HPLC has become one of the most widely used instrumental 
analytical systems. This is perhaps due to the wide range of available 
columns (normal phase, reversed phase and ion exchange), along with 
the variety of selectivity introduced by change in mobile phase 
composition. HPLC provides selectivity, simplicity of separation 
methods, and reproducibility. 
These properties lead to the wide variety of applications of 
HPLC, ranging from separation of aromatic hydrocarbons, 
pharmaceuticals, and pesticides to applications in bioanalysis. 
Irrespective of the type of analysis, the goal is to provide information 
about the composition of the sample, purity, content, and possible 
available impurities (33). 
3.2.1. Selection of the mobile phase 
The assessment for good separation was judged through good 
capacity factor, peak symmetry and resolution factor with 
reproducible retention time, (Table 6) reflects the preliminary trials 
carried to optimize the chromatographic conditions which can give 
satisfactory resolution for these compounds (see appendix).  
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These criteria were obtained when using 15:3:82v/v 
acetonitrile: tetrahydrofuran: 1%v/v aqueous phosphoric acid, at a 
flow rate of 1.5 ml/min. the elution order was dorzolamide 
hydrochloride at 2.52min (K’ value 1.1), and timolol maleate at 4.48 
(K’ value 2.73) (Fig. 8). 
 
Figure 8: A typical chromatogram of the eye drops solution injected 
showing dorzolamide hydrochloride at 2.52min retention time and 
timolol maleate peak at 4.48min retention time. 
3.2.2. Linearity 
 A calibration curve was prepared using a mixture of the drugs 
at concentration of 120-480 µg/ml for timolol maleate and 360-1440 
µg/ml for dorzolamide hydrochloride. The obtained correlation 
coefficient values (r) for timolol maleate were (0.9992) and for 
dorzolamide hydrochloride were (0.999), the regression analysis data 
was calculated at 95% confidence level for the slope (b ± tsb) and the 
intercept (a ± tsa) using the formula 
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P = (b ± tsb) x + (a ± tsa)     (29) 
where P is the peak area, b the slope, sb the standard deviation for the 
slope, the t-value at 95% confidence level for (n – 2), sa the standard 
deviation for the intercept, and x the concentration (µg/ml) 
 The results for dorzolamide hydrochloride were 
P = (342868 ± 8439.72) x + (84586557 ± 8320777.026) 
 And the results for timolol maleate were 
P = (1386224.6 ± 1709.005) x + (61886441 ± 7949064.352) 
These results indicated good distribution of points along the 
linearity range. 
 The method was applied for the determination of these 
compounds in eye drops formulation marketed in Sudan (XolamolTM) 
which contains timolol maleate and dorzolamide hydrochloride in a 
ratio of 1:3. 
 Both timolol maleate and dorzolamide hydrochloride are good 
UV-absorbing compounds with ? max at about 315.8 and 250.3nm 
respectively. However in the study we found that using ? max at 275nm 
gave good response for both drugs according to their ratio in the eye 
drops. 
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3.2.3. Assay 
  Both peak areas and peak heights were utilized in the analytes 
concentration determination. (Table 7) reflects that either peak area or 
peak height can be utilized for the determination of the analytes 
concentrations (SD values less than 0.7). 
Table 7: Data for assay results ± SD utilizing peak areas and peak 
heights for dorzolamide hydrochloride and timolol maleate 
Drug Utilizing peak area  Utilizing peak height 
Dorzolamide 
hydrochloride 
100.25 ± 0.62 
n=6 
99.67 ± 0.38 
n=6 
Timolol maleate 100.08 ± 0.24 
n=6 
99.79 ± 0.51 
n=6 
 
 The stability of the eye drops constituents in their original 
packing was assessed by exposing the container to sunlight (1 day) or 
after being left at room temperature for seven days. No change of 
concentration or change of retention times was observed. 
3.2.4. Precision 
The effect of the eye drops matrix on the assay was checked by 
the recovery addition method. The results showed good recovery: 
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100.67±1.29 n=3 for timolol maleate (added concentration was 
136.8µg/ml) and 100.24±0.99 n=3 for dorzolamide hydrochloride 
(added concentration was 445.2µg/ml). These results showed clearly 
that the eye drops matrix did not affect the assay results obtained by 
the present assay method. 
The validity of the presented method was assessed by 
calculating the accuracy from the assay results, the t-values were 
calculated considering the actual content is 100% for each (known 
mean) according to the formula 
t = (x - µ)ξn/s 
where x is the mean, µ is the known mean, n is the number of 
determinations, s is standard deviation (29). 
 Table 8 reflects the t values obtained, which ascertained 
accuracy of the developed method. 
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Table 8: The calculated t values compared to the tabulated values for 
the analysis of dorzolamide hydrochloride and timolol maleate 
Drug                t-values (n – 1) 
Utilizing peak area Utilizing peak height 
Dorzolamide 
hydrochloride 
 0.78(cal.) 
 2.57(tab.) 
 1.31(cal.) 
 2.57(tab.) 
Timolol maleate  0.04(cal.) 
 2.57(tab.) 
 0.72(cal.) 
 2.57(tab.) 
 
3.2.5. Limit of detection and limit of quantification: 
Limit of detection and limit of quantification were calculated 
from the calibration curve results. They were found to be 5.95µ g/ml 
and 18.03µ g/ml for timolol maleate, and 25.18µg/ml and 76.31µg/ml 
for dorzolamide hydrochloride. The low levels indicate that the 
method is sensitive and suitable for the determination of timolol 
maleate and dorzolamide hydrochloride in the presence of each other. 
Tables 9 and 10 describe the steps used to calculate the limits of 
detection and limit of quantification. 
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Table 9: Calculation of limits of detection and limit of quantification 
for dorzolamide hydrochloride 
Xi Xi2  Yi Ýi (Yi   Ýi)2 
(×1012) 
(Xi -X¯)2 
360 129600 206367117 208019332.8 2.729817 291600 
720 518400 333732273 331452108.1 5.199152 32400 
1080 1166400 455281201 454884883.4 0.157068 32400 
1440 2073600 577293392 578317658.7 1.049121 291600 
 ? = 
3888000 
  ? = 
9.128770 
? = 
648000 
r = 0.9999  a = 84586557.5 b = 342868.82 
Sy/x = ටଽǤଵଶ଼଻଻ൈଵ଴
భమ
ଶ
   = 2136442.136 
Sb = 
ଶଵଷ଺ସସଶǤଵଷ଺
ξ଺ସ଼଴଴଴
  = 2654.018 
Sa = 2136442.136× ට
ଷ଼ ଼଼଴଴଴
ସൈ଺ସ଼଴଴଴
 = 2616596.549 
L.O.D. = ଷǤଷൈଶ଺ଵ଺ହଽ଺Ǥହସଽ
ଷସଶ଼଺଼Ǥ଼ଶ
 = 25.18µg/ml 
L.O.Q. = ଵ଴ൈଶ଺ଵ଺ହଽ଺Ǥହସଽ
ଷସଶ଼଺଼ Ǥ଼ଶ
  = 76.31µg/ml 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
ϲϭ 
 
Table 10: calculation of limits of detection and limit of quantification 
for timolol maleate 
Xi Xi2  Yi Ýi (Yi   Ýi)2 (Xi - 
X¯)2 
120 14400 227115946 228233390.5 1.248682×1012 32400 
240 57600 396094117 394580339.5 2.291522×1012 3600 
360 129600 561252076 560927288.5 0.102481×1012 3600 
480 230400 726553126 727274237.5 0.520002×1012 32400 
 ? = 
432000 
  ? = 
4.165686×1012 
? = 
72000 
 
r = 0.9999  a = 61886441 b = 1386224.6 
Sy/x = ටସǤଵ଺ହ଺଼଺ൈଵ଴
భమ
ଶ
   = 1443205.807 
Sb = 
ଵସସଷଶ଴ହǤ଼଴଻
ξ଻ଶ଴଴଴
  = 5378.51 
Sa = 1443205.807× ට
ସଷଶ଴଴଴
ଶൈ଻ଶ଴଴଴
 = 2499705.771 
L.O.D. = ଷǤଷൈଶସଽଽ଻଴ହǤ଻଻ଵ
ଵଷ଼଺ଶଶସǤ଺
 = 5.95µg/ml 
L.O.Q. = ଵ଴ൈଶସଽଽ଻଴ହǤ଻଻ଵ
ଵଷ଼଺ଶଶସǤ଺
  = 18.03µg/ml 
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 The result of this study is published at Elixir pharmacy journal 
in August 2011 (34) (see appendix). 
3.3. Antazoline hydrochloride and tetrahydrozoline hydrochloride  
A drug analyst is mainly concerned with the establishment of 
analytical methods capable of assaying drugs in their different dosage 
forms. Single drug formulations are generally easier to analyze; 
however multi formulations require more sophisticated methods 
capable of assaying each component in a mixture without interference 
from the other. Spectrophotometry (UV/VIS) is the mostly used 
technique in drug analysis; however, spectrophotometry did not proof 
to be a suitable tool for the assay in even single drug formulation in 
the presence of interfering excepients or drug decomposition products 
which can lead to irrelevant absorption or overlapping spectra. These 
limitations of the UV-VIS instrument lead to the rise of 
chromatographic technique in drug analysis. Thus chromatography in 
general and HPLC in particular became among the most frequently 
used methods in drug analysis due to its advantage as a separation 
tool. HPLC presents the analyst with a tool favorably suitable for 
assay of single or multiple component system without the limitations 
mentioned for UV-VIS instrument. HPLC is also a tool for drug 
stability studies. 
Both isocratic and gradient elution can be adopted in HPLC to 
develop stability indicating methods; however, isocratic separation 
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would be preferred as it is easy to conduct, and does not need much 
skill or sophisticated instrument. The availability of the broad 
spectrum columns makes isocratic separation more suitable for 
compounds that are separable only by gradient elution. 
3.3.1. Selection of the mobile phase 
Different mobile phases composed of different percentage of 
acetonitrile; THF and phosphoric acid aqueous solution were tried 
with different flow rates. A 20:4:76v/v acetonitrile: THF: 1%v/v 
phosphoric acid aqueous solution at a flow rate of 1.5ml/min showed 
the peak of tetrahydrozoline at 2.82 min and peak of antazoline at 
10.12mins with a remarkable tailing in the second peak; the polarity 
index of the system was 9.072. A 22: 5: 73 at a flow rate of 1.5ml/min 
eluted the first peak at 2.18min and the second peak at 6.58min 
leading to interference between the first peak and a negative peak 
appeared in the chromatogram; the polarity index of this system was 
8.9. A 25: 5: 70 at a flow rate of 1.4ml/min eluted the peak of 
tetrahydrozoline at 2.28min and that of antazoline at 5.66min; again 
the interference with the negative peak was observed, the polarity 
index for this system was 8.7. A 18: 5: 77 at a flow rate of 1.8ml/min 
gave good results. The peak of tetrahydrozoline was eluted away from 
the negative peak appearing at 2.25min and the peak of antazoline at 
8.17min, the polarity index of this system was 9.098 (Fig. 9). 
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Figure 9: A typical chromatogram of the eye drops solution using 
sulphamethoxazole as internal standard (a is the peak of 
tetrahydrozoline hydrochloride, b is the peak of sulphamethoxazole 
(internal standard) and c is the peak of antazoline hydrochloride) 
The relatively large resolution value (about 26) between the two 
peaks leads to the search for a suitable internal standard to fit between 
the two peaks. The internal standard was used to minimize possible 
errors during injection (30). A number of drugs were tested for their 
use as internal standard including chloramphenicol, trimethoprim, 
dorzolamide, timolol, caffeine and sulphamethoxazole. All these 
drugs were eluting close to the tetrahydrozoline peak (retention times 
between 2.43-2.7min) except sulphamethoxazole which eluted at 
6.87min, therefore it was selected as the suitable internal standard. For 
any stability studies on these drugs, the internal standard can be 
omitted so as to check for any degradation products that can elute 
before or after these two drugs. 
Re
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 (m
Vo
lt)
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The optimized percentage of THF improved the peaks 
symmetry. The change in acetonitrile affected the retention time of the 
peaks. The increase in acetonitrile lead to decrease in the retention 
times of both peaks. However, the decrease in retention time of 
tetrahydrozoline lead to its elution with the negative peak. 
It also worth noting that not only the polarity index of the 
mobile phase is a sufficient criteria for good resolution and peak 
symmetry, but also the ratio of solvent mixture composing the mobile 
phase is important. This is confirmed by comparing results obtained 
for solvent mixtures of polarity 9.072 and the other solvent mixture 
with polarity index 9.098. 
3.3.2. Assay 
The developed method was applied for the determination of 
these compounds in eye drops formulation marketed in Sudan; 
Apillerg and OptizolinTM which contains antazoline hydrochloride and 
tetrahydrozoline hydrochloride. Both peak area ratio and peak height 
ratio were utilized in the determination of the analytes concentration. 
Table (30) shows the obtained results for the assays for both of trade 
names of drugs. 
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Table 11: Results of the assay for Apillerg and OptizolinTM using the 
developed method 
 
 
Drug 
                     Recovery % (mean ± SD) 
Apillerg OptizolinTM 
peak area 
ratio 
peak height 
ratio 
peak area 
ratio 
peak height 
ratio 
Tetrahydrozolin
e hydrochloride 
99.98 ± 0.19 
n=13 
99.74 ± 0.32 
n=13 
93.78±0.10 
n=5 
97.04±0.43 
n=5 
Antazoline 
hydrochloride 
100.02 ± 0.04 
n=13 
99.98 ± 0.49 
n=13 
96.98±0.04 
n=5 
96.96±0.42 
n=5 
 
3.3.3. Linearity 
A calibration curve was prepared using a mixture of the drugs 
at concentration of 12-48 µ g/ml for tetrahydrozoline hydrochloride 
and 20-80 µ g/ml for antazoline hydrochloride. The obtained 
correlation coefficient values (r) for tetrahydrozoline was (0.9997) 
and for antazoline hydrochloride was (0.9997). The regression 
analysis data was calculated at 95% confidence level for the slope (b ± 
tsb) and the intercept (a ± tsa) using the formula 
P = (b ± tsb) x + (a ± tsa) (29) 
where P is the peak area ratio, b the slope, sb the standard deviation 
for the slope, the t value at 95% confidence level for (n – 2), sa the 
standard deviation for the intercept, and x the concentration (µ g/ml) 
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The results for tetrahydrozoline hydrochloride were 
P = (0.0236 ± 0.0011) x + (0.1146 ± 0.0256) 
The results for antazoline hydrochloride were 
P = (0.0203 ± 0.0009) x + (0.3950 ± 0.0508) 
These results indicated good distribution of points along the linearity 
range. 
Reliability and validity of the results was assessed through the 
following factors. Calculation for the true mean using the formula: 
 µ confidence interval = X¯ ± ௧௦
ξ௡
 
Where µ is the true mean, X¯ is the mean, t is the t-value at 95% 
confidence level for (n - 1), s is the standard deviation, and n is the 
number of determinations (31). 
The result for tetrahydrozoline hydrochloride was found to be 
99.98 ± 0.24 and for antazoline hydrochloride was 100.02 ± 0.04. This 
reflects the confidence limits of µ (true mean) for n- replicate results. 
Comparison of the results with a true value (µ=100) was done 
using the formula 
t = (x - µ) ξn/s 
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where x is the mean, µ is the known mean, n is the number of 
determinations, s is standard deviation (31). Table 12 shows the 
comparison. 
Table 12: The calculated t values for the determination of antazoline 
hydrochloride and tetrahydrozoline hydrochloride compared to the 
tabulated values 
Drug t-values (n – 1) 
Utilizing peak 
area ratio 
Utilizing peak 
height ratio 
tetrahydrozoline hydrochloride 0.24(cal.) 
2.78 (tab.) 
1.82 (cal.) 
2.78  (tab.) 
Antazoline hydrochloride 1.12 (cal.) 
2.78 (tab.) 
0.09 (cal.) 
2.78  (tab.) 
 
The effect of the eye drops matrix on the assay was checked by 
the recovery addition method. The results showed good recovery: 
101.02±1.65 n=3 for tetrahydrozoline hydrochloride and 99.48±0.33 
n=3 for antazoline hydrochloride. They were calculated using the 
following formula 
݌௧െ݌௦௠
݌௦௧ௗ
 
Where Pt  is the total peak ratio (sample and standard), Psm is the 
sample peak ratio and Pstd is the standard peak ratio (35). 
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These results reflected that the eye drops matrix did not affect 
the assay results obtained by the present method. 
3.3.4. Precision 
Between-days and within-day precisions were determined for 
three different concentrations at low, medium, and high levels of the 
standard curve. RSD values were calculated and were within the 
accepted limits (less than 2%) (Table 13).  
Table 13: Precision of the developed method for the analysis of 
antazoline hydrochloride and tetrahydrozoline hydrochloride 
drug The 
conc. 
(µg/
ml) 
Found 
conc.(mean 
± SD)* 
Within-
day 
precision 
(RSD %) 
Found 
conc.(mean 
± SD)** 
Between
-day 
precision 
(RSD %) 
Tetrahydrozolin
e hydrochloride 
12 12.41±0.05 0.40 12.16±0.24 1.97 
32 31.06±0.11 0.32 31.64±0.57 1.80 
48 48.52±0.06 0.12 48.20±0.32 0.66 
Antazoline 
hydrochloride 
20 19.31±0.02 0.10 19.58±0.27 1.38 
48 48.28±0.03 0.06 48.26±0.02 0.04 
80 79.43±0.05 0.06 79.66±0.23 0.29 
*within-day 
**between-day 
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3.3.5. Limit of detection and limit of quantification 
Limit of detection and limit of quantification were calculated 
from the calibration curve results. They were found to be 1.86µg/ml 
and 5.66µg/ml for tetrahydrozoline hydrochloride, and 2.66µg/ml and 
8.06µg/ml for antazoline hydrochloride. The low levels indicate that 
the method is sensitive and suitable for the determination of 
tetrahydrozoline hydrochloride and antazoline hydrochloride in the 
presence of each other or separately. Tables 14 and 15 describe the 
steps used to calculate the limits of detection and limit of 
quantification. 
 Table 14: Calculation of limits of detection and limit of quantification 
for tetrahydrozoline hydrochloride 
Xi Xi2  Yi Ýi (Yi   Ýi)2 (Xi - X¯)2 
12 144 0.3969 0.3969 2.601× 10-5 324 
24 576 0.6796 0.6788 7.053× 10-7 36 
32 1024 0.8684 0.8667 2.941× 10-6 4 
36 1296 0.9719 0.9606 1.266× 10-4 16 
48 2304 1.2338 1.2425 7.629× 10-5 324 
 ? = 5344   ? =232.5463×10-6 ? =704 
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r = 0.9997  a = 0.1146  b = 0.0236 
Sy/x = ටଶଷଶǤହସ଺ଷൈଵ଴
షల
ଷ
   = 8.804×10-3 
Sb = 
Ǥ଼଼଴ସൈଵ଴షయ
ξ଻଴ସ
  = 3.318×10-4 
Sa = 8.804×10-3× ට
ହଷସସ
ହൈ଻଴ସ
 = 13.366×10-3 
L.O.D. = ଷǤଷൈଵଷǤଷ଺଺ൈଵ଴
షయ
଴Ǥ଴ଶଷ଺
 = 1.869µg/ml 
L.O.Q. = ଵ଴ൈଵଷǤଷ଺଺ൈଵ଴
షయ
଴Ǥ଴ଶଷ଺
  = 5.664µg/ml 
Table 15: Calculation of limit of detection and limit of quantification 
for antazoline hydrochloride 
Xi Xi2  Yi Ýi (Yi   Ýi)2 (Xi -X¯)2 
20 400 0.4309 0.4448 1.930× 10-4 900 
40 1600 0.8668 0.8501 2.782× 10-4 100 
48 2304 1.0178 1.0123 3.076× 10-5 4 
60 3600 1.2549 1.2555 3.037× 10-7 100 
80 6400 1.6530 1.6608 6.053× 10-5 900 
 ? =14304   ? = 5.628× 10-4 ? =2004 
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r = 0.9997  a = 0.0395  b = 0.0203 
Sy/x = ටହǤ଺ଶ଼ൈଵ଴
షర
ଷ
   = 3.059×10-4 
Sb = 
ଷǤ଴ହଽൈଵ଴షర
ξଶ଴଴ସ
  = 0.0137 
Sa = 3.059×10-4× ට
ଵସଷ଴ସ
ହൈଶ଴଴ସ
 = 0.016 
L.O.D. = ଷǤଷൈ଴Ǥ଴ଵ଺
଴Ǥ଴ଶ଴ଷ
 = 2.66µg/ml 
L.O.Q. = ଵ଴ൈ଴Ǥ଴ଵ଺
଴Ǥ଴ଶ଴ଷ
  = 8.063µg/ml 
 
Two HPLC methods have been reported for the determination 
of antazoline and tetrahydrozoline combination, one of these methods 
is using a reversed-phase ion-pair HPLC (16, 17). Although the ion-
pairing reagent can solve the problem of peak tailing, it is considered 
harmful for the column. There will be a need for daily washing of the 
column and the tubing and after assays is completed. In the present 
work, a simple mobile phase is used composed of acetonitrile, THF 
and aqueous phosphoric acid solution, which are not harmful to the 
column. The THF used in this mobile phase was found to improve the 
peak shape markedly and there was no need for the use of an ion-
pairing reagent (peak symmetry was 1.1 for tetrahydrozoline and 
sulphamethoxazole and 1.2 for antazoline). 
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The method described by Huang et. al. for the assay of 
tetrahydrozoline in ophthalmic formulations (13) seems to suffer from 
the problem of loss of baseline restoration due to the high 
concentration of sulphamethoxazole. This problem is not observed in 
the present method since sulphamethoxazole elutes after 
tetrahydrozoline. The current presented method can therefore be 
successfully used for the assay of tetrahydrozoline and 
sulphamethoxazole in combination utilizing antazoline as internal 
standard. 
The present developed method can be considered a contribution to the 
assay of this combination in addition to the reported HPLC methods 
(16, 17). 
The degradation products of tetrahydrozoline (A) and antazoline ( B ) 
(3), are more polar than their corresponding parent compounds and 
will elute earlier in each case. The method described in the present 
study can therefore be adopted as a stability indicating method for 
both drugs. 
            
(1RS)-1, 2, 3, 4-tetrahydronaphthalene-1-carbonitrile (a-
cyanotetraline). (A) 
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N-(2-aminoethyl)-2-(benzylphenylamino) acetamide. (B)  
 
 Results of this study has been accepted for publication by 
International Journal of Drug Formulation and research, not yet 
published. 
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3.4. Conclusion 
· HPLC method for determination of dexamethasone 
sodium phosphate – chloramphenicol in ophthalmic 
solutions was developed. The method is considered 
simple, linear, accurate, sensitive and reproducible. 
· HPLC method for determination of dorzolamide 
hydrochloride - timolol maleate in eye drops 
formulations was developed. The developed is 
considered simple, linear, accurate, sensitive and 
reproducible. 
· HPLC method for the determination of tetrahydrozoline 
hydrochloride - antazoline hydrochloride in ophthalmic 
preparations. The method is considered simple, linear, 
accurate, sensitive and reproducible.  
· These methods can be successfully used for the routine 
quality control of all three combinations within a short 
analysis time (less than 10 minutes).  
· The method can also be utilized for the assay of each 
drug alone using either compound as internal standard for 
the other.  
· The third developed method can also be utilized for the 
assay of sulphamethoxazole (internal standard) using 
either of the drugs as internal standard for it.  
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· Also it is possible to use this system for the assay of the 
drugs tested as internal standard in this study. 
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3.5. Recommendations: 
· The robustness, ruggedness and stability indicating 
properties make the developed methods suitable for 
routine analysis of these combinations. 
· The methods can also be used for the routine analysis 
of each of the drugs alone or in combination. 
· There is no pharmacopoeial method for the assay of 
these three combinations. From the results obtained in 
the present work it is suggested that the three 
developed methods can be subjected to collaborative 
studies to evaluate their suitability as pharmacopoeial 
methods for the assay of these combinations. 
· The methods are also considered easy to conduct and 
can replace old methods of analysis for each drug. 
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Table 1: Trials to optimize a suitable system for the simultaneous determination of dexamethasone sodium 
phosphate and chloramphenicol 
Mobile phase 
Flow 
Rate 
Dexamethasone 
sodium phosphate Chloramphenicol 
 
T0* 
 
Resol
ution Tr ** 
K’**
* 
Peak 
sym Tr K’ 
Peak 
sym 
20:80Acetonitrile: 1% v/v acetic acid 
1.00 
Almost overlapping 
36:64Acetonitrile: 1% v/v acetic acid 1.00 3.75 1.21 1.07 6.70 2.49 1.09 1.70 3.92 
25:75Acetonitrile: 1% v/v acetic acid 1.50 10.15 4.97 1.27 11.45 5.74 1.09 1.70 1.30 
36:64Acetonitrile: water 1.00 2.08 1.97 0.75 6.31 8.01 1.20 0.70 2.12 
36:64Acetonitrile: Na acetate 0.01M  
pH 3.6 
 
1.00 
 
Peak appeared with the solvent front 
50:50Acetonitrile: 1% v/v acetic acid 1.00 Peak appeared with the solvent front 
36:64Acetonitrile: 1% v/v acetic acid 1.30 1.80 0.63 1.11 4.40 3.00 1.00 1.10 5.78 
36:64Acetonitrile: 1% v/v acetic acid 1.50 1.80 0.89 1.07 3.82 3.02 1.10 0.95 2.89 
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36:64Acetonitrile: 3% v/v acetic acid 1.50 2.10 1.21 1.20 3.70 2.89 1.00 0.95 2.67 
36:64Acetonitrile: 5% v/v acetic acid 1.50 2.23 1.23 1.08 3.47 2.47 1.00 1.00 2.07 
0.01 M KH2PO4 in 50:50 methanol:water 1.50 3.18 5.04 1.30 6.62 1.77 1.14 1.30 6.54 
*T0  unretained peak 
   **Tr retention time 
 ***K’ capacity factor 
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Table 6:  Results of system optimization trials for analysis of dorzolamide hydrochloride and timolol maleate 
 
Mobile phase 
 
Flo
w 
rate 
 
T0* 
Dorzolamide 
hydrochloride 
Timolol maleate 
 
Resol
ution 
Tr** K’*** 
Peak 
sym 
Tr K’ 
Peak 
sym 
18:82 Acetonitrile:5%v/v acetic acid 1.50 1.50 2.40 0.60 1.20 5.45 2.60 1.69 1.04 
18:82 Methanol:5% acetic acid 1.50 1.50 2.20 0.46 1.00 9.95 5.64 1.64 3.69 
25:75 Acetonitrile:5%v/v acetic acid 1.50 1.60 2.10 0.31 1.14 3.43 1.14 1.44 0.99 
25:75 Acetonitrile:Na phosphate 0.01 M pH3.6 1.50 1.25 2.83 1.26 1.60 4.65 2.72 1.86 0.33 
25:75 Acetonitrile:5%v/v acetic acid 1.80 1.45 1.90 0.31 1.00 2.83 0.95 1.44 0.72 
18:5:77  acetonitrile:THF:5%v/v acetic acid 1.50           The peak of timolol maleate showed splitting 
10:90THF:5%v/v acetic acid 1.50 2.00 3.17 0.58 1.08 3.72 0.86 1.47 1.00 
22:78 acetonitrile:1%v/v ammonia 1.50               The peaks were tailing badly 
5:5:90 Acetonitrile:THF:2.5% v/v acetic acid 1.50 1.60 2.80 0.75 1.18 4.47 1.79 1.64 1.07 
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5:5:90 Acetonitrile:THF:2.5% v/v acetic acid + 
2ml phosphoric acid 
 
1.50 
 
1.90 
 
3.00 
 
0.57 
 
1.17 
 
5.14 
 
1.71 
 
1.31 
 
2.30 
15:85 Acetonitrile:1%v/v phosphoric acid 1.50 2.00 2.93 0.47 1.20 8.42 3.21 1.66 2.85 
15:3:82 
Acetonitrile:THF:1%v/v phosphoric acid 
 
1.50 
 
1.20 
 
2.52 
 
1.10 
 
1.10 
 
4.48 
 
2.73 
 
1.08 
 
1.63 
0.01 M KH2PO4 in 50:50 methanol:water 1.50 2.20 2.72 0.24 1.00 4.57 1.08 1.30 2.85 
     *T0  unretained peak 
   **Tr retention time 
 ***K’ capacity factor 
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